This program is dedicated to the training of cardiovascular scientists with MD and/or PhD degrees. Over the past 15 years, the program has been highly successful with particular emphasis on producing investigators working in developmental biology, genetics, signal transduction, and vascular biology. Five years ago, the scope of the scientific opportunities within the program was broadened to allow trainees to gain new competencies in functional genomics, complex multigenic disorders, cardiovascular gene therapy, genomic pharmacology, molecular imaging, and myocardial cell biology. Cardiovascular science has continued to make dramatic advances. Stem cell biology appears poised to change our understanding of myocardial and endothelial biology. Proteomics and high-throughput chemical genetic screening are rapidly changing the scale and speed with which investigators characterize novel signal transduction pathways, and ultimately will accelerate the development of new therapies. New insights into the molecular mechanisms involved in cardiac myocyte hypertrophy and dysfunction, as well as pulmonary arterial hypertension, have important therapeutic implications for an expanding population of patients with cardiopulmonary disorders. To enable trainees to benefit from these advances and to rapidly become pioneers in cardiovascular science, new faculty have been recruited who are recognized leaders in these evolving fields, as well as proven, outstanding mentors. The program remains based at the Cardiovascular Research Center at the Massachusetts General Hospital with additional training sites at Harvard University, Massachusetts Institute of Technology, and the Broad Institute. Training is firmly centered on laboratory science under the supervision of skilled primary and secondary mentors, with unique opportunities for innovation at the interface between fields and supervised development of interdisciplinary collaborative skills. Course work is tailored to the needs of the trainee with didactic experiences serving to broaden exposure to the forefront of cardiovascular science. The faculty and trainees are closely linked by the tradition of collaboration and a shared training mission. Importantly, an enhanced CVRC seminar series, Data Club, CVRC retreat, and CVRC website serve to bring all of the trainees together on a regular basis and provide a sense of community. Trainee progress is closely monitored by the mentors, the program director and co-director, and a Steering Committee, with additional advice provided by an External Advisory Committee. Mentorship itself is both trained and evaluated. Graduates of this training program are systematically prepared to lead independent research programs at the cutting edge of cardiovascular science for the coming decades.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007208-35
Application #
8286999
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Carlson, Drew E
Project Start
1993-07-01
Project End
2013-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
35
Fiscal Year
2012
Total Cost
$444,117
Indirect Cost
$51,406
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Benson, Mark D; Yang, Qiong; Ngo, Debby et al. (2018) Genetic Architecture of the Cardiovascular Risk Proteome. Circulation 137:1158-1172
Hu, Ray; Morley, Michael P; Brandimarto, Jeffrey et al. (2018) Genetic Reduction in Left Ventricular Protein Kinase C-? and Adverse Ventricular Remodeling in Human Subjects. Circ Genom Precis Med 11:e001901
Jacob, Jaison; Ngo, Debby; Finkel, Nancy et al. (2018) Application of Large-Scale Aptamer-Based Proteomic Profiling to Planned Myocardial Infarctions. Circulation 137:1270-1277
Khera, Amit V; Chaffin, Mark; Aragam, Krishna G et al. (2018) Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet 50:1219-1224
Jordi, Josua; Guggiana-Nilo, Drago; Bolton, Andrew D et al. (2018) High-throughput screening for selective appetite modulators: A multibehavioral and translational drug discovery strategy. Sci Adv 4:eaav1966
Paffett-Lugassy, Noelle; Novikov, Natasha; Jeffrey, Spencer et al. (2017) Unique developmental trajectories and genetic regulation of ventricular and outflow tract progenitors in the zebrafish second heart field. Development 144:4616-4624
Tucker, Nathan R; McLellan, Micheal A; Hu, Dongjian et al. (2017) Novel Mutation in FLNC (Filamin C) Causes Familial Restrictive Cardiomyopathy. Circ Cardiovasc Genet 10:
Tucker, Nathan R; Dolmatova, Elena V; Lin, Honghuang et al. (2017) Diminished PRRX1 Expression Is Associated With Increased Risk of Atrial Fibrillation and Shortening of the Cardiac Action Potential. Circ Cardiovasc Genet 10:
Strauss, David G; Vicente, Jose; Johannesen, Lars et al. (2017) Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study. Circulation 135:1300-1310
Hucker, William J; Hanley, Alan; Ellinor, Patrick T (2017) Improving Atrial Fibrillation Therapy: Is There a Gene for That? J Am Coll Cardiol 69:2088-2095

Showing the most recent 10 out of 188 publications